A DNA aptamer with high affinity and specificity for therapeutic anthracyclines.

We describe the characterization of a DNA aptamer that displays high affinity and specificity for the anthracyclines daunomycin and doxorubicin, both of which are frequently used in chemotherapy. Aptamers were isolated from a pool of random sequences using a semiautomated procedure for magnetic beads. All selected aptamers displayed high affinity for the target molecule daunomycin. One aptamer was further characterized and exhibited a dissociation constant (KD) of 20 nM. To examine the aptamer's binding properties and clarify its applicability for diagnostic assays, its performance under various buffer conditions was evaluated. The aptamer proved to be very robust and not dependent on the presence of specific ions. It also tolerated a wide pH range and immobilization via 5'-biotinylation. Furthermore, a competition assay for sensitive daunomycin detection was established. This not only allows the determination of the aptamer's specificity but also allows the quantification of as little as 8.4 microg/L daunomycin and doxorubicin.

[1]  S. Moro,et al.  Anthracyclines: recent developments in their separation and quantitation. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[2]  D. Drolet,et al.  An enzyme-linked oligonucleotide assay , 1996, Nature Biotechnology.

[3]  C. K. Smith,et al.  DNA-nogalamycin interactions: the crystal structure of d(TGATCA) complexed with nogalamycin. , 1994, Biochemistry.

[4]  Hideki Kuramitz,et al.  Evaluation of Binding Between Electroactive Biotin Derivative and Streptavidin Immobilized on Chitin Film , 2005 .

[5]  Jörn Glökler,et al.  Nonradioactive fluorescence microtiter plate assay monitoring aptamer selections. , 2007, BioTechniques.

[6]  P. Marquet,et al.  Simultaneous determination of four anthracyclines and three metabolites in human serum by liquid chromatography-electrospray mass spectrometry. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[7]  R M Mader,et al.  Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. , 2007, Chemosphere.

[8]  Alexandre Restrepo,et al.  Aptasensor development: elucidation of critical parameters for optimal aptamer performance. , 2004, Analytical chemistry.

[9]  J. Glökler,et al.  Application of aptamers in therapeutics and for small-molecule detection. , 2006, Handbook of experimental pharmacology.

[10]  Martina Rimmele,et al.  Nucleic Acid Aptamers as Tools and Drugs: Recent Developments , 2003, Chembiochem : a European journal of chemical biology.

[11]  Aniela Wochner,et al.  Semi-automated selection of DNA aptamers using magnetic particle handling. , 2007, BioTechniques.

[12]  S K Carter,et al.  Adriamycin. A new anticancer drug with significant clinical activity. , 1974, Annals of internal medicine.

[13]  Takeshi Saito,et al.  Generation of inhibitory DNA aptamers against human hepatocyte growth factor. , 2005, DNA and cell biology.

[14]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[15]  E. Vermaas,et al.  Selection of single-stranded DNA molecules that bind and inhibit human thrombin , 1992, Nature.

[16]  J. Szostak,et al.  In vitro selection of functional nucleic acids. , 1999, Annual review of biochemistry.

[17]  Juewen Liu,et al.  A simple and sensitive "dipstick" test in serum based on lateral flow separation of aptamer-linked nanostructures. , 2006, Angewandte Chemie.

[18]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[19]  N. Bachur,et al.  Daunorubicin metabolism in acute myelocytic leukemia. , 1972, Blood.

[20]  D. Hougaard,et al.  Distribution of anticancer antibiotic daunomycin in the rat heart and kidney revealed by immunocytochemistry using monoclonal antibodies , 2006, Histochemistry and Cell Biology.

[21]  J. SantaLucia,et al.  A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. S. Sastry,et al.  Determination of doxorubicin hydrochloride by visible spectrophotometry. , 1996, Talanta.

[23]  M. Siddiqui,et al.  Pegaptanib , 2012, Drugs.

[24]  M. Yarus,et al.  Selection of an RNA domain that binds Zn2+. , 1995, RNA.

[25]  Jeffery T. Davis.  G-quartets 40 years later: from 5'-GMP to molecular biology and supramolecular chemistry. , 2004, Angewandte Chemie.

[26]  Shankar Balasubramanian,et al.  Prevalence of quadruplexes in the human genome , 2005, Nucleic acids research.

[27]  D. Alberts,et al.  The pharmacokinetics of daunomycin in man , 1971, Clinical pharmacology and therapeutics.

[28]  R. Stoltenburg,et al.  FluMag-SELEX as an advantageous method for DNA aptamer selection , 2005, Analytical and bioanalytical chemistry.

[29]  M. Famulok,et al.  RNA aptamers specifically interact with the prion protein PrP , 1997, Journal of virology.

[30]  J. Beijnen,et al.  Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatography. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[31]  M. Reggiani,et al.  ON PHYSICO-CHEMICAL INTERACTIONS BETWEEN DAUNOMYCIN AND NUCLEIC ACIDS. , 1965, Biochimica et biophysica acta.

[32]  Yingfu Li,et al.  Structure-switching signaling aptamers: transducing molecular recognition into fluorescence signaling. , 2004, Chemistry.

[33]  Manju Patel,et al.  A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. , 2005, Ophthalmology.

[34]  P. Canal,et al.  Anthracycline analysis by capillary electrophoresis. Application to the analysis of daunorubicine in Kaposi sarcoma tumor. , 1999, Journal of chromatography. A.

[35]  D. Walt,et al.  A fiber-optic microarray biosensor using aptamers as receptors. , 2000, Analytical biochemistry.

[36]  C. Salata,et al.  A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children. , 1999, Blood.

[37]  J. Szostak,et al.  In vitro selection of RNA aptamers specific for cyanocobalamin. , 1994, Biochemistry.

[38]  Shankar Balasubramanian,et al.  G-quadruplexes in promoters throughout the human genome , 2006, Nucleic acids research.

[39]  Michael Famulok,et al.  Allosteric aptamers and aptazymes as probes for screening approaches. , 2005, Current opinion in molecular therapeutics.

[40]  P. He,et al.  Study on the Interaction between Antitumor Drug Daunomycin and DNA , 2005 .

[41]  A. Ellington,et al.  Adapting selected nucleic acid ligands (aptamers) to biosensors. , 1998, Analytical chemistry.

[42]  C. Haanen,et al.  In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells. , 1988, European journal of cancer & clinical oncology.

[43]  A. Bast,et al.  Antioxidant capacity of reaction products limits the applicability of the Trolox Equivalent Antioxidant Capacity (TEAC) assay. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[44]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[45]  J. van der Greef,et al.  Bioanalysis of some anthracyclines in human plasma by capillary electrophoresis with laser-induced fluorescence detection. , 1992, Journal of chromatography.

[46]  T Pérez-Ruiz,et al.  Simultaneous determination of doxorubicin, daunorubicin, and idarubicin by capillary electrophoresis with laser‐induced fluorescence detection , 2001, Electrophoresis.

[47]  F. Innocenti,et al.  An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma. , 1999, Therapeutic drug monitoring.

[48]  Andrew D. Ellington,et al.  Nucleic acid selection as a tool for drug discovery , 1998 .

[49]  T. Porstmann,et al.  Comparison of Chromogens for the Determination of Horseradish Peroxidase as a Marker in Enzyme Immunoassay , 1981, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.